ZDF
Sign inSign up

Vulnerabilities

Vulnerability · CVE-2025-64298

NMIS/BioDose V22.02 and previous version installations where the embedded Microsoft SQLServer Express is used are exposed in the Windows share accessed by clients in networked inst

Published Dec 2, 2025 · catalog updated Dec 9, 2025 · Mirion Medical EC2 Software NMIS BioDose

Last checked Oct 27, 2026. A connected source was read within the last 7 days.

Check if you run it

No confirmed exploitation is on record for CVE-2025-64298. EPSS is 0.23%. Act only if a listed version of Mirion Medical EC2 Software NMIS BioDose is installed.

Gaps on this record

  • No vendor fix or required action is stored. Compare the linked advisory before you change production.

Same product and reporting

Severity
High8.6
Known exploitation
Not in CISA/VulnCheck KEV
EPSS
0.23%
Remediation
Version ranges on file
Affected products
vendor Mirion Medical EC2 Software NMIS BioDose 0 <23.0

NMIS/BioDose V22.02 and previous version installations where the embedded Microsoft SQLServer Express is used are exposed in the Windows share accessed by clients in networked installs. By default, this directory has insecure directory paths that allow access to the SQL Server database and configuration files, which can contain sensitive data.

Are you affected?

Enter the version you run. The result uses only the ranges stored on this record.

The check returns affected, not affected, or incomplete. It does not guess a version that is missing from the record.

  • vendor Mirion Medical EC2 Software NMIS BioDose 0 <23.00 <23.0

How to fix CVE-2025-64298

What to do

Three questions, each answered from this record only. Confirm the vendor advisory before you patch.

Should you patch?

No confirmed exploitation is on record for CVE-2025-64298. EPSS is 0.23%. Act only if a listed version of Mirion Medical EC2 Software NMIS BioDose is installed.

Which versions are affected?

Compare what you have installed with Mirion Medical EC2 Software NMIS BioDose 0 <23.0 0 <23.0. Compare the installed version with the linked vendor advisory before you change production.

What should an analyst verify?

No weakness class is stored. EPSS 0.23%. There is no CISA KEV listing. No Exploit-DB or Metasploit reference is linked. Use the source links for the original advisory.

Technology hubs

Windows security

Code

The project this record applies to. Exploit listings stay in References.

No public source repository is identified for this product.

Timeline

Detection, updates, and resolution for this record.

  1. Dec 2, 2025 · EUVD

    Detected

    NMIS/BioDose V22.02 and previous version installations where the embedded Microsoft SQLServer Express is used are exposed in the Windows share accessed by clients in networked installs. By default, this directory has insecure directory paths that allow access to the SQL Server database and configuration files, which can contain sensitive data.

  2. Dec 9, 2025 · EUVD

    Updated

    NMIS/BioDose V22.02 and previous version installations where the embedded Microsoft SQLServer Express is used are exposed in the Windows share accessed by clients in networked installs. By default, this directory has insecure directory paths that allow access to the SQL Server database and configuration files, which can contain sensitive data.

Sources

  • CVE.orgVulnerability recordCVE-2025-64298

    Official CVE identifier

    cve.org
  • FIRST EPSSExploitation probabilityCVE-2025-64298

    30-day exploitation probability 0.23%

    first.org
  • EUVDVulnerability recordEUVD-2025-200323

    NMIS/BioDose V22.02 and previous version installations where the embedded Microsoft SQLServer Express is used are exposed in the Windows share accessed by clients in networked installs. By default, this directory has insecure directory paths that allow access to the SQL Server da

    euvd.enisa.europa.eu

References

Freshness

Last verified in this catalog Oct 27, 2026. Significant claims (KEV, EPSS, CVSS, affected ranges) come from the source rows above — open the original publisher for the authoritative advisory.

  • CVE.orgOct 27, 2026
  • FIRST EPSSOct 27, 2026
  • EUVDOct 27, 2026